Insights into juvenile myositis via engineered muscle.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37495869.
- Also identified by DOI 10.1038/s41584-023-01003-6 and PMC identifier 11259152.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The pathogenesis of juvenile dermatomyositis (JDM) is complex and various evidence implicate a role for type I interferons. Could the use of a bioengineered paediatric skeletal muscle model provide insight into this disease and have potential for high throughput testing of therapeutic agents?
Medical subject headings
- Dermatomyositis
- Myositis